TREATMENT ADHERENCE TO CONVENTIONAL AND BIOLOGIC DISEASE MODIFYING ANTIRHEUMATIC DRUGS IN PATIENTS WITH RHEUMATOID ARTHRITIS

被引：1
|
作者：
Feldman, C. H. [1 ]
Lii, J. [1 ]
Gopalakrishnan, C. [1 ]
Franklin, J. M. [1 ]
Kim, S. C. [1 ]
机构：
[1] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.5544
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0664
引用
收藏
页码：526 / 526
页数：1
相关论文
共 50 条
  • [1] Treatment adherence to disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis
    Xia, Yunfei
    Yin, Rulan
    Fu, Ting
    Zhang, Lijuan
    Zhang, Qiuxiang
    Guo, Genkai
    Li, Liren
    Gu, Zhifeng
    PATIENT PREFERENCE AND ADHERENCE, 2016, 10 : 735 - 742
  • [2] ADHERENCE TO BIOLOGIC AND CONVENTIONAL DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Mishra, P.
    VALUE IN HEALTH, 2018, 21 : S198 - S198
  • [3] Adherence of rheumatoid arthritis patients to biologic disease-modifying antirheumatic drugs: a cross-sectional study
    Natalia Mena-Vazquez
    Sara Manrique-Arija
    Lucía Yunquera-Romero
    Inmaculada Ureña-Garnica
    Marta Rojas-Gimenez
    Carla Domic
    Francisco Gabriel Jimenez-Nuñez
    Antonio Fernandez-Nebro
    Rheumatology International, 2017, 37 : 1709 - 1718
  • [4] MEDICATION ADHERENCE IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS: A REGISTER STUDY
    Joensuu, J. T.
    Aaltonen, K. J.
    Valleala, H.
    Puolakka, K.
    Yli-Kerttula, T.
    Varjolahti-Lehtinen, T.
    Sokka, T.
    Blom, M.
    Nordstrom, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 882 - 883
  • [5] Adherence of rheumatoid arthritis patients to biologic disease-modifying antirheumatic drugs: a cross-sectional study
    Mena-Vazquez, Natalia
    Manrique-Arija, Sara
    Yunquera-Romero, Lucia
    Urena-Garnica, Inmaculada
    Rojas-Gimenez, Marta
    Domic, Carla
    Gabriel Jimenez-Nunez, Francisco
    Fernandez-Nebro, Antonio
    RHEUMATOLOGY INTERNATIONAL, 2017, 37 (10) : 1709 - 1718
  • [6] ANNUAL TREATMENT COST OF BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS
    Hosseini, R.
    Brown, L. M.
    Fleming, M.
    Rodriguez-Monguio, R.
    Seoane-Vazquez, E.
    VALUE IN HEALTH, 2024, 27 (06) : S110 - S110
  • [7] Effectiveness of treatment with biologic- and disease-modifying antirheumatic drugs in rheumatoid arthritis patients in Colombia
    Machado-Alba, J. E.
    Ruiz, A. F.
    Machado-Duque, M. E.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2016, 70 (06) : 506 - 511
  • [8] Conventional disease-modifying antirheumatic drugs to treat rheumatoid arthritis
    Rath, T.
    Sander, O.
    Rubbert, A.
    DRUG DEVELOPMENT RESEARCH, 2011, 72 (08) : 657 - 663
  • [9] BONE STATUS OF RHEUMATOID ARTHRITIS PATIENTS TREATED WITH BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS
    Miladi, S.
    Ben Ayed, H.
    Makhlouf, Y.
    Boussaa, H.
    Ouenniche, K.
    Souabni, L.
    Kassab, S.
    Chekili, S.
    Ben Abdelghani, K.
    Fazaa, A.
    Laatar, A.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S447 - S447
  • [10] Factors Associated with the Use of Biologic Disease-modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis
    Hosseini, Roya
    Fawaz, Souhiela
    Seoane-Vazquez, Enrique
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2595 - 2595
12345